These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 13655659)

  • 1. Clearing system for blood fats; stimulation by a heparinoid.
    DUNCAN CH; BEST MM; McGAFF CJ
    Lancet; 1959 May; 1(7081):1014-6. PubMed ID: 13655659
    [No Abstract]   [Full Text] [Related]  

  • 2. [On influencing the physiological coagulation time and the clearing factor by total body inunction with alpha-heparin and heparinoid ointments].
    STUETTGEN G; BRUESTER H
    Dermatol Wochenschr; 1960 Jan; 141():97-102. PubMed ID: 13835417
    [No Abstract]   [Full Text] [Related]  

  • 3. [COMPARISON OF SOME EFFECTS OF HEPARIN AND THE PERORAL HEPARINOID "ATEROID" IN RATS].
    CEPELIK J; CERNOHORSKY M
    Cas Lek Cesk; 1963 Nov; 102():1291-4. PubMed ID: 14111755
    [No Abstract]   [Full Text] [Related]  

  • 4. [CLEARING ACTION OF HEPARIN AND HEPARINOID SUBSTANCES IN THERAPY OF ARTERIOSCLEROSIS].
    MEONI G
    Clin Ter; 1965 Mar; 32():445-60. PubMed ID: 14333171
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of a natural heparinoid with sodium and calcium heparin for their effect on the inhibitor of activated factor X.
    Mannucci PM; di Santo C; Franchi F
    Experientia; 1976 Nov; 32(11):1478-80. PubMed ID: 62674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human plasma heparin levels and lipemia clearing activity after ingestion of animal and vegetable fat.
    ENGELBERG H
    J Appl Physiol; 1958 Sep; 13(2):296-8. PubMed ID: 13575347
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the effect of a conventional heparin and a low molecular weight heparinoid on platelet function.
    Mikhailidis DP; Barradas MA; Mikhailidis AM; Magnani H; Dandona P
    Br J Clin Pharmacol; 1984 Jan; 17(1):43-8. PubMed ID: 6197984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the detection of local and systemic actions of heparin as well as heparinoid ointments].
    STUETTGEN G; BRUESTER H; SCHULGEN W
    Arzneimittelforschung; 1962 Jul; 12():723-7. PubMed ID: 13917990
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies by ultracentrifuge and paper electrophoresis on the effects of heparin and heparinoid substance on the lipoproteins in the serum of cholesterol-fed rabbits.
    NAKAMURA H; FUJITA H; OKUYAMA F
    Jpn J Physiol; 1956 Feb; 5(Suppl):375-81. PubMed ID: 13318784
    [No Abstract]   [Full Text] [Related]  

  • 10. [HEPARINOIDS--PHYSIOLOGICAL PROPERTIES AND THERAPEUTIC INDICATIONS].
    GUILLEMAN P; HARDY N
    Rev Prat; 1964 Oct; 14():3391-405. PubMed ID: 14205831
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparinoid and heparin; an investigation into the anticoagulant effect of the dextran sulphate dexulate.
    ARGE E
    Acta Med Scand; 1956 Nov; 155(6):469-74. PubMed ID: 13372201
    [No Abstract]   [Full Text] [Related]  

  • 12. [Esterolytic activity of serum following administration of heparinoid].
    PLACER Z; SLABOCHOVA Z; ROUBAL Z
    Cesk Fysiol; 1959 Apr; 8(3):236-7. PubMed ID: 13671575
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect in man of a new heparinoid, treburon.
    FIELD JB; RAMSAY GD; ATTYAH AM; STARR P
    J Lab Clin Med; 1953 Feb; 41(2):208-14. PubMed ID: 13035252
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of a heparinoid extract on the total serum cholesterol and the alpha and beta lipoprotein fractions].
    MANCINI M; D'ANDREA L; ORIENTE P; GUERRIERI R; MAIORANO G
    Minerva Med; 1960 Feb; 51():389-91. PubMed ID: 14420509
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of the clarifying activity in vitro of serum after the addition of various heparinoid substances].
    WOLFF R; BRIGNON JJ
    Arch Int Pharmacodyn Ther; 1959 Sep; 121():255-67. PubMed ID: 13845713
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the behavior of the plasma "clearing factor" after the administration of a synthetic heparinoid].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1498-9. PubMed ID: 13807122
    [No Abstract]   [Full Text] [Related]  

  • 17. [The increase of thrombin inhibitor in the blood after percutaneous administration of a heparinoid].
    WITTE S; BRESSEL D
    Klin Wochenschr; 1960 May; 38():501. PubMed ID: 13845470
    [No Abstract]   [Full Text] [Related]  

  • 18. [Activation of fibrinolysis and thrombolysis by polysaccharide sulfuric acid esters (heparin, heparinoid)].
    HALSE T
    Arzneimittelforschung; 1962 Jun; 12():574-82. PubMed ID: 13904008
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of blood lipase before and after heparin injections].
    STORK A; KUCEROVA L
    Cas Lek Cesk; 1956 Mar; 95(11):286-7. PubMed ID: 13316795
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heparin influence on the lipase and esterase level in human blood].
    SKOREPA J; TODOROVICOVA H
    Cas Lek Cesk; 1956 Mar; 95(11):289-93. PubMed ID: 13316797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.